Covered recipient · General Payments record
TYLER LYMAN MARLER
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2019–2024
$2,541.35
- Reported across 90 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $663.85 | 29 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $299.58 | 9 |
| Novo Nordisk AS | $113.33 | 6 |
| GlaxoSmithKline, LLC. | $53.50 | 3 |
| Lilly USA, LLC | $42.70 | 2 |
| PFIZER INC. | $41.29 | 3 |
| Esperion Therapeutics, Inc. | $22.75 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $19.29 | 1 |
| Exact Sciences Corporation | $18.30 | 1 |
| Abbott Laboratories | $17.84 | 1 |
| Acerta Pharma LLC | $17.65 | 1 |
| Amgen Inc. | $17.62 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (29)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $17.84 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124932473 | CMS |
| ABBVIE INC. | $33.36 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104969071 | CMS |
| ABBVIE INC. | $31.47 | 04/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104969073 | CMS |
| ABBVIE INC. | $27.32 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104969075 | CMS |
| ABBVIE INC. | $31.34 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104969077 | CMS |
| ABBVIE INC. | $29.90 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104969079 | CMS |
| ABBVIE INC. | $109.85 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104969081 | CMS |
| ABBVIE INC. | $19.96 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104969083 | CMS |
| ABBVIE INC. | $13.64 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104969085 | CMS |
| ABBVIE INC. | $2.74 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104969087 | CMS |
| Amgen Inc. | $17.62 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117620026 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.65 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105459972 | CMS |
| Esperion Therapeutics, Inc. | $22.75 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129445798 | CMS |
| Exact Sciences Corporation | $18.30 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114509233 | CMS |
| GlaxoSmithKline, LLC. | $19.43 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116497811 | CMS |
| GlaxoSmithKline, LLC. | $19.02 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116440211 | CMS |
| GlaxoSmithKline, LLC. | $15.05 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116332857 | CMS |
| Lilly USA, LLC | $23.82 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135451272 | CMS |
| Lilly USA, LLC | $18.88 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135469061 | CMS |
| Novartis Pharmaceuticals Corporation | $19.29 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087138110 | CMS |
| Novo Nordisk Inc | $19.03 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096572250 | CMS |
| Novo Nordisk Inc | $24.19 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097339295 | CMS |
| Novo Nordisk Inc | $23.81 | 07/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097008586 | CMS |
| Novo Nordisk Inc | $13.40 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097399647 | CMS |
| Novo Nordisk Inc | $15.80 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097538198 | CMS |
| Novo Nordisk Inc | $17.10 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096581582 | CMS |
| PFIZER INC. | $14.03 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131677315 | CMS |
| PFIZER INC. | $13.53 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131936304 | CMS |
| PFIZER INC. | $13.73 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131193822 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.